STAR EXPORT HOUSE
We are dedicated to serving a wide range of clients, such as non-governmental organizations (NGOs), medical facilities like hospitals, wholesalers (resellers), local pharmacies, and large pharmaceutical corporations. Focusing solely on the distribution of generic medications, our company is committed to providing top-notch products that are both high in quality and cost-effective. Our goal is to address the diverse healthcare requirements of our international customer base by offering reliable and affordable generic medicines.
We are a highly reputable pharmaceutical sourcing company that specializes in procuring and distributing a diverse selection of top-notch generic and branded medications on a global scale. Our expertise is well-known in the industry, and we have built a strong reputation for our ability to acquire high-quality pharmaceutical products. Our primary focus is on sourcing medicines from reputable manufacturers in India, a country recognized for its advanced pharmaceutical manufacturing capabilities. We are dedicated to upholding the highest standards of quality and safety in our product selection process. This involves rigorous quality control measures to ensure that the medications we provide are not only effective but also safe for consumption. Our ultimate goal is to provide cost-effective and dependable healthcare solutions that meet the varied requirements of our clients worldwide.
The pharmaceutical contract manufacturing process involves the outsourcing of drug production to third-party manufacturers. This means that pharmaceutical companies delegate the manufacturing of their drugs to specialized external companies instead of producing them in-house. These third-party manufacturers have the expertise, facilities, and equipment necessary to produce pharmaceutical products on behalf of the companies that hire them. In addition, this process often includes the transfer of technology and knowledge from the pharmaceutical company to the contract manufacturer to ensure that the products are manufactured according to specific quality standards and regulatory requirements. The use of advanced technologies such as artificial intelligence and machine learning plays a crucial role in optimizing various stages of drug development and manufacturing. These technologies can help streamline processes, improve efficiency, enhance quality control, and ultimately accelerate the production of pharmaceutical products.
exSell laboratories Pvt Ltd is registered in Mumbai, India.
Validated Cold Chain Shipment.
Cold Chain Validation is a critical process that involves testing and documenting the temperature-controlled environment in which products are stored and transported. It is essential for ensuring compliance with regulations and quality standards, as well as maintaining the integrity of the products by keeping them within the specified temperature range throughout the supply chain. Failure to properly validate the cold chain can result in compromised product quality, safety concerns, and regulatory non-compliance. By conducting thorough cold chain validation, companies can demonstrate that their products have been handled and transported under suitable conditions, thereby ensuring their efficacy and safety for end-users.
We are committed to catering to a diverse clientele, including non-governmental organizations (NGOs), medical facilities such as hospitals, wholesalers acting as resellers, local pharmacies, and large pharmaceutical corporations. Specializing in the distribution of generic medications, our company is dedicated to delivering premium-quality products that are not only effective but also budget-friendly. Our primary objective is to meet the varied healthcare needs of our global customers by supplying dependable and reasonably priced generic medicines.
Named-patient basis is a regulatory pathway that enables healthcare providers to request access to medications that are not available in the market for a particular patient they are treating. This process involves the physician directly contacting the pharmaceutical company to procure the medication for the individual patient's use. This approach is usually reserved for situations where standard treatments have been exhausted, and the patient's condition necessitates alternative or investigational therapies. It requires careful consideration of the patient's medical history, the potential benefits of the medication, and any associated risks. The named-patient basis is a means to provide access to potentially life-saving treatments outside of the traditional approval process, offering a lifeline for patients facing serious or rare conditions.